COMMUNIQUÉS West-GlobeNewswire

CROSSJECT publie ses résultats financiers 2025 et confirme le renforcement de sa trajectoire opérationnelle, industrielle et financière
24/03/2026
DIJON, France – 24 mars 2026 (18H30 CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique de spécialités qui développe des produits dédiés aux situations d’urgence fondés sur sa technologie [...]
Tatwa Integrative Medicine Establishes Itself as Europe's Reference for Amazonian Floral Essences and Launches Its 10th Vibratory Elixir
24/03/2026
The Colombian-Swiss company Tatwa Integrative Medicine is cementing its leadership in the integrative medicine and wellness market with the launch of Tabaco, a floral essence for clarity, energetic protection and inner [...]
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
24/03/2026
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography [...]
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
24/03/2026
Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, [...]
Leo International Precision Health AG approves cash capital increase excluding subscription rights
24/03/2026
Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 24. Mar 2026 / 17:44 CET/CEST [...]
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
24/03/2026
IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price. IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade [...]
Adjustment of guidance for 2025/26
24/03/2026
ANNOUNCEMENT NO. 303 24 March 2026 Adjustment of guidance for 2025/26 Over the past period, ChemoMetec's most important market, the North American market for cell and gene therapy, has been affected by three factors [...]
Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026
24/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 24 MARCH 2026 at 16.30 EET Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March [...]
Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease
24/03/2026
HOUSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be [...]
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
24/03/2026
ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the [...]
SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing
24/03/2026
RANCHO CORDOVA, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- SK pharmteco , a leading global contract development and manufacturing organization (CDMO), and Prozomix , a pioneer in enzyme discovery and diversity, today [...]
SurvivorRx Expands Personalized Supplement Routines as Oncologists Raise Concerns About Supplement Safety for Cancer Survivors
24/03/2026
New oncology- and naturopath-informed supplement systems aim to simplify post-treatment wellness while addressing safety, dosing, and formulation challenges many survivors face JACKSONVILLE, Fla., March 24, 2026 (GLOBE [...]
San Juan Regional Medical Center Selects Full PerfectServe Platform for Enterprise Communication and Scheduling Overhaul
24/03/2026
Unique platform breadth, advanced capabilities, integrated patient-family communication, highly collaborative project team made PerfectServe the clear choice MIAMI and FARMINGTON, N.M., March 24, 2026 (GLOBE NEWSWIRE [...]
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
24/03/2026
Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting highly prevalent KRAS [...]
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
24/03/2026
TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Authority has entered into a Clinical Trial [...]
Lace-Up Ankle Brace Support Gets Comfort Upgrade and Removable Side Stabilizers
24/03/2026
Lynden, WASHINGTON, March 24, 2026 (GLOBE NEWSWIRE) -- Z Athletics has announced an upcoming updated version of its flagship lace-up ankle brace, featuring upgraded comfort materials and new removable semi-rigid side [...]
Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans
24/03/2026
H.R. 7091 Supports Development of Investigational Treatments for Alcohol Use Disorder and Aligns with Evolving Federal Recovery Standards GLEN ALLEN, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( [...]
CenTrak Advances Its RTLS Platform Through Enhanced Healthcare Integrations
24/03/2026
CenTrak receives Epic Toolbox designation and Rauland® VIP Program validation, highlighting interoperable, scalable solutions that streamline clinical workflows and system connectivity NEWTOWN, Pa., March 24, 2026 ( [...]
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
24/03/2026
Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor, demonstrating potential best-in-class reductions in inflammatory biomarkers of [...]

Pages